| Drug delivery: a process governed by species-specific lipophilicities K Mazák, B Noszál European Journal of Pharmaceutical Sciences 62, 96-104, 2014 | 47 | 2014 |
| Lipophilicity of vinpocetine and related compounds characterized by reversed-phase thin-layer chromatography K Mazák, J Vámos, A Nemes, Á Rácz, B Noszál Journal of Chromatography A 996 (1-2), 195-203, 2003 | 45 | 2003 |
| Physicochemical profiling of baicalin along with the development and characterization of cyclodextrin inclusion complexes G Jakab, D Bogdán, K Mazák, R Deme, Z Mucsi, IM Mándity, B Noszál, ... AAPS PharmSciTech 20, 1-12, 2019 | 44 | 2019 |
| Advances in microspeciation of drugs and biomolecules: Species-specific concentrations, acid-base properties and related parameters K Mazák, B Noszál Journal of Pharmaceutical and Biomedical Analysis 130, 390-403, 2016 | 34 | 2016 |
| Zwitterions can be predominant in membrane penetration of drugs: experimental proof K Mazák, B Noszál Journal of Medicinal Chemistry 55 (15), 6942-6947, 2012 | 26 | 2012 |
| Proton speciation and microspeciation of serotonin and 5‐hydroxytryptophan K Mazák, V Dóczy, J Kökösi, B Noszál Chemistry & Biodiversity 6 (4), 578-590, 2009 | 24 | 2009 |
| Species-specific lipophilicity of thyroid hormones and their precursors in view of their membrane transport properties G Tóth, K Mazák, S Hosztafi, J Kökösi, B Noszál Journal of pharmaceutical and biomedical analysis 76, 112-118, 2013 | 23 | 2013 |
| Lipophilicity of morphine microspecies and their contribution to the lipophilicity profile K Mazák, B Noszál European journal of pharmaceutical sciences 45 (1-2), 205-210, 2012 | 23 | 2012 |
| Lipophilicity of zwitterions and related species: a new insight K Mazák, J Kökösi, B Noszál European journal of pharmaceutical sciences 44 (1-2), 68-73, 2011 | 23 | 2011 |
| Structural and physicochemical profiling of morphine and related compounds of therapeutic interest. K Mazák, S Hosztafi, Á Rácz, B Noszál Mini Reviews in Medicinal Chemistry 9 (8), 984-995, 2009 | 19 | 2009 |
| Physico-chemical profiling of semisynthetic opioids K Mazák, S Hosztafi, M Kraszni, B Noszál Journal of Pharmaceutical and Biomedical Analysis 135, 97-105, 2017 | 18 | 2017 |
| Advances in the physicochemical profiling of opioid compounds of therapeutic interest K Mazák, B Noszál, S Hosztafi ChemistryOpen 8 (7), 879-887, 2019 | 17 | 2019 |
| Proton speciation and microspeciation of vinpocetine and related compounds in aqueous and biomimetic media K Mazák, A Nemes, B Noszál Pharmaceutical research 16, 1757-1763, 1999 | 17 | 1999 |
| Species-specific lipophilicity of morphine antagonists K Mazák, S Hosztafi, B Noszál European Journal of Pharmaceutical Sciences 78, 1-7, 2015 | 16 | 2015 |
| Physicochemical properties of zwitterionic drugs in therapy K Mazák, B Noszál ChemMedChem 15 (13), 1102-1110, 2020 | 14 | 2020 |
| Thyroxine lipophilicity is dominated by its zwitterionic microspecies K Mazák, G Tóth, J Kökösi, B Noszál European journal of pharmaceutical sciences 47 (5), 921-925, 2012 | 14 | 2012 |
| The interaction of enoxaparin and fondaparinux with calcium K Mazák, CN Beecher, M Kraszni, CK Larive Carbohydrate research 384, 13-19, 2014 | 13 | 2014 |
| Capillary electrophoresis separation of vinpocetine and related compounds: Prediction of electrophoretic mobilities in partly aqueous media K Mazák, Z Szakács, A Nemes, B Noszál ELECTROPHORESIS: An International Journal 21 (12), 2417-2423, 2000 | 11 | 2000 |
| Physicochemical and pharmacological characterization of permanently charged opioids K Mazak, B Noszal, S Hosztafi Current Medicinal Chemistry 24 (33), 3633-3648, 2017 | 10 | 2017 |
| Novel data on the effect of tetrahydrofuran as an organic co-modifier in RP-HPLC P Horváth, A Gergely, K Mazák, J Kökösi, G Szász Chromatographia 76, 441-448, 2013 | 9 | 2013 |
